deoxypyridinoline has been researched along with Paraneoplastic Syndromes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braun, HJ; Deicher, H; Fett, W; Harms, P; Kindler, U; Klinkenstein, C; Peest, D; Planker, M; Schäfer, E; Schumacher, K; Siecke, H | 1 |
1 trial(s) available for deoxypyridinoline and Paraneoplastic Syndromes
Article | Year |
---|---|
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG).
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers, Tumor; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Humans; Middle Aged; Multiple Myeloma; Neoplasm Staging; Paraneoplastic Syndromes; Peptides; Pilot Projects | 1996 |